ØU Biotech nr. 16: IPO-aktierne steg 13% i Q3 2017
Acarix, ADDvice, Alligator Bioscience, ALK-Abelló, Annexin Pharmaceuticals, AstraZeneca, BergenBio, Biotec Pharmacon, Bonesupport, Camurus, Corline Medical, Diamyd Medical, Enorama Pharma, Genmab, Genovis, Getinge Group, Herantis Pharma, Immune Pharmaceuticals, Kancera, Medical Prognosis Institute, Medivir, Moberg Pharma, NeuroVive, Novo Nordisk, Nuevolution, Photocure, Recipharm, Scibase, Senzime, Targovax, Saniona og Össur.